SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Nexalin Technology, Inc. (NXL) News

Follow Nexalin Technology, Inc. (NXL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol NXL Asset equity Sector Markets 90 days 12 Last 1.54 Updated Oct 02, 2026, 02:30 PM UTC Open live news feed Open NXL chart & news
H Dow Jumps Over 300 Points; US Economy Adds 29,000 Jobs In September U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Friday. The Dow traded up 0.63% to 51,246.54 while the NASDAQ jumped 1.74% to 27,338.20. The S&P 500 also rose, gaining, 1. LIVE | Oct 02, 2026, 02:30 PM UTC H Nasdaq Gains 100 Points; ISM manufacturing PMI Slips In September U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.06% to 50,936.24 while the NASDAQ rose 0.37% to 26,960.69. The S&P 500 also rose, gai LIVE | Oct 01, 2026, 05:54 PM UTC L Nexalin Technology, Inc. (NXL) Names DiTota Senior Strategic Advisor for Global Commercialization Nexalin Technology appointed neuromodulation veteran Robert DiTota as Senior Strategic Advisor, Global Commercialization, to guide distribution and go-to-market for its DIFS platform in approved markets and future U.S./E NEWS | Sep 29, 2026, 01:08 PM UTC L Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy Appointment as Senior Strategic Advisor marks the Company’s expansion from clinical development toward commercialization of its DIFS™ platform in the United States, Europe and South AmericaDiTota spent over two decades i NEWS | Sep 29, 2026, 01:08 PM UTC L Nexalin Technology DiTota's Appointment Effective Sept. 15 >NXL Nexalin Technology DiTota's Appointment Effective Sept. 15 >NXL NEWS | Sep 29, 2026, 01:02 PM UTC L Nexalin Technology Appoints Robert DiTota Senior Strategic Advisor >NXL Nexalin Technology Appoints Robert DiTota Senior Strategic Advisor >NXL NEWS | Sep 29, 2026, 01:01 PM UTC L Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard On September 25, 2026, the company received a Nasdaq Hearings Panel notice granting continued listing subject to meeting the $1.00 minimum bid price by September 28, 2026 and the $2.5 million stockholders' equity require NEWS | Sep 28, 2026, 09:26 PM UTC L Nuix Recognised as a RiskTech100® 2027 Disruptor by Chartis Research SYDNEY, Sept. 25, 2026 // -- Nuix (ASX:NXL), a global leader in investigative analytics and intelligence software, announced it has been named a Disruptor in the Risk Infrastructure category of the Chartis RiskTech100® 2 NEWS | Sep 25, 2026, 12:35 AM UTC L Greenlight Ventures discloses 5.6% stake in Nexalin Technology Greenlight Ventures, LLC disclosed a 5.6% stake in Nexalin Technology, Inc.'s common stock. The filing was accepted Sep. 03, 2026, after stock was issued as non-cash consideration for Nexalin's purchase of PONM. EQUITY | Sep 03, 2026, 05:39 PM UTC L Nexalin Technology reports secondary analysis improvements in Alzheimer’s trial data Nexalin Technology said further ADAS-Cog data analysis from its randomized, sham-controlled trial found improvements tied to memory domains in Alzheimer’s patients. The Company plans to use ADAS-Cog subscale results for EQUITY | Sep 03, 2026, 12:37 PM UTC L Nexalin says Carolyn Shelton exits senior vice president role Nexalin said Carolyn Shelton departed as Senior Vice President of Quality, Regulatory and Clinical Affairs, effective August 28, 2026, under a separation agreement covering bonus and option vesting. REGULATION | Sep 02, 2026, 09:05 PM UTC L Nexalin Technology announces reverse stock split Nexalin Technology announced a reverse stock split. EQUITY | Aug 27, 2026, 11:27 AM UTC L NXL: Wins Award Nexalin Technology's investigator receives Young Researcher Award for evaluating the company's DIFS platform EQUITY | Jun 23, 2026, 12:30 PM UTC